Nova Hub

Dec
2024

Changes in Director’s Interest (Section 219 of CA 2016) – MR LAI TEIK KIN

NOVA MSC BERHAD 09 December 2024 Information Compiled By KLSE Particulars of Director Name MR LAI TEIK KIN Descriptions(Class) Ordinary Shares Details of changes No Date of change No of securities Type of transaction Nature of Interest 1 05/12/2024 15,000,000 Others Direct Interest Name of registered holder Lai Teik Kin Description of “Others” Type of Transaction Conversion of ICPS Consideration (if…

Read more

Dec
2024

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 06 December 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 16,056,000 Issue price per share Malaysian Ringgit (MYR)   0.0400 Par Value (if applicable)…

Read more

Dec
2024

KASIH IBU HOSPITAL IN BALI ACHIEVES STAGE 6 EMRAM

4 Dec 2024 – Nova congratulates Kasih Ibu Hospital Group’s flagship hospital in Denpasar, capital of Bali, Indonesia for being validated for Stage 6 of the HIMSS Electronic Medical Record Adoption Model (EMRAM). The HIMSS EMRAM is a global standard that measures the use of technology to transform healthcare to improve patient safety, care quality and efficiency. Stage 6, on…

Read more

Dec
2024

NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”)

NOVA MSC BERHAD 03 December 2024   Type Announcement Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING Description NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”)   Reference is made to the Company’s announcements…

Read more

Dec
2024

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 20 December 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 20,200,000 Issue price per share Malaysian Ringgit (MYR)   0.0400 Par Value (if applicable)…

Read more

Nov
2024

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2024

NOVA MSC BERHAD 28 November 2024   Financial Year End 31 Mar 2025 Quarter 2 Qtr Quarterly report for the financial period ended 30 Sep 2024 The figures have not been audited   NMSC_report_FY2425_2Qtr.pdf

Nov
2024

OTHERS Nova MSC Berhad (NOVAMSC OR THE COMPANY) Joint Venture and Shareholders’ Agreement between NOVAMSC and Theta Edge Berhad (“THETA”)

NOVA MSC BERHAD 27 November 2024   Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC OR THE COMPANY) Joint Venture and Shareholders’ Agreement between NOVAMSC and Theta Edge Berhad (“THETA”)   We refer to the announcement dated 5 September 2023, in relation to the Joint Venture and Shareholders’ Agreement between the Company and THETA. Unless otherwise stated, all definitions…

Read more

Nov
2024

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 15 November 2024   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 915,700 Issue price per share Malaysian Ringgit (MYR)   0.0400 Par Value (if…

Read more

Nov
2024

NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”)

NOVA MSC BERHAD 14 November 2024   Type Announcement Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING Description NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”)   Reference is made to the Company’s announcements…

Read more

Oct
2024

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 30 October 2024   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 400,000 Issue price per share Malaysian Ringgit (MYR)   0.0400 Par Value (if…

Read more

Oct
2024

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 23 October 2024   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 150,000 Issue price per share Malaysian Ringgit (MYR)   0.0400 Par Value (if…

Read more

Oct
2024

EYRIS SIGNS MOU WITH AL-DAWAA MEDICAL SERVICES IN KSA

21 Oct 2024  – On Monday, Singapore Ambassador to the Kingdom of Saudi Arabia, Mr Premijit Sadasivan, presided over the signing ceremony of a MOU between EyRIS and Al-Dawaa Medical Services Co. EyRIS is a Singapore healthtech company providing AI-based health screening, while Al-Dawaa is one of the largest pharmacy chains and healthcare solution distributors in the Kingdom of Saudi…

Read more